•  
  •  
 

Central Asian Journal of Medicine

Abstract

Objective: Identification of tactics and results of radical surgical treatment of patients with renal cell carcinoma with intraluminal venous invasion. Material and methods: over a 10-year period, records of case histories and outpatient records of 76 patients with the presence of tumor masses in the lumen of the inferior vena cava, with the upper level up to the diaphragm, which underwent expanded nephrectomy with thrombectomy from the inferior vena cava were analyzed. The operative approach was determined on the basis of the cranial level of the caval tumor localization established during preoperative diagnostic studies. Results: long-term follow-up established for all patients. 17 patients lived with metastases from 5 to 36 months. The average survival time after surgery is 32 months. One- and three-year survival rates were respectively 75 and 51%. Conclusions: all patients managed to achieve a reduction in the clinical manifestations of the disease and prolonged survival.

First Page

174

Last Page

189

References

1. Buylov V.M., Borisano A.V., Osintsev A.V. Ratsional'noye ispol'zovaniye mnogofazovoy spiral'noy komp'yuternoy tomografii pri rake pochki // Nevskiy radiol. forum. – SPb, 2005. – S. 35-36. 2. Vaganov N.V., Vazhenin A.V. Vysokiye tekhnologii v onkologii. Materialy 5-go Vserossiyskogo s"yezda onkologov. – Kazan', 2000. – T. 1. – S. 273-274. 3. Glazun L.O., Polukhina Ye.V. Ul'trazvukovaya diagnostika zabolevaniy pochek. – M.: Izd. dom Vidar-M, 2014. – 296 s. 4. Zukov R.A. Lecheniye pochechno-kletochnogo raka: vozmozhnosti, problemy, perspektivy // Sibirskoye med. obozreniye. – 2013. – №3. – S. 105-111. 5. Komarov R.N., Belov YU.V., Chernyavskiy S.V., Galnykina Ye.K. Khirurgicheskoye lecheniye bol'nogo rakom pravoy pochki i opukholevym trombozom nizhney poloy veny, pravogo predserdiya posle raneye perenesennogo aortokoronarnogo shuntirovaniya // Khirurgiya. – 2016. – №3. – S. 64-66. 6. Matveyev B.P. Klinicheskaya onkourologiya. – M.: ABV Press, 2011. – 934 s. 7. Mit'kova V.V. prakticheskoye rukovodstvo po ul'trazvukovoy diagnostike. – M.: Izd. dom Vidar-M, 2011. – 2-ye izd. – 712 s. 8. Khitrova A.N., Mit'kov V.V., Mit'kova M.D. Ul'trazvukovaya diagnostika zabolevaniy pochek // Prakticheskoye rukovodstvo po ul'trazvukovoy diagnostike; Pod. red. V.V. Mit'kova. – M.: Izd. dom Vidar-M, 2005. – 338 s. 9. Ardekani R.G., Hunter J.A., Thomson A. Hidden hypernephroma simulating right atrial tumor // Ann. Thorac. Surg. – 1971. – Vol. 11. – P. 371-375. 10. Berg A.A. Malignant hypernephroma of the kidney // Surg. Gynecol. Obstet. – 1913. – Vol. 17. – P. 463–471. 11. Bissada N.K., Yakout H.H., Babanouri A. et al. Long-term experience with management of renal cell carcinoma in volving thein ferior vena cava // Urology. – 2003. – Vol. 61, №1ю – P. 89-92. 12. Blute M.L., Leibovich B.C., Lohse C.M. et al The Mayo-Clinic experience with surgical management complications and outcome for patients with renal cell carcinoma and venous tumour thrombus // Brit. J. Uril. Int. – 2004. – Vol. 94, №1. – P. 33-41. 13. Haferkamp A., Bastian P.J., Jakobi H. et al. Renal cell carcinoma with tumor thromb us extension in to the vena cava: prospective long-term followup // J. Urol. – 2007. – Vol. 177, №5. – P. 1703-1708 14. Janowitz T., Welsh S.J., Zaki K. et al. Adjuvant therapy in renal cell carcinoma – past, present, and future // Semin. Oncol. – 2013. – Vol. 40. – P. 482-491. 15. Lotan Y., Karam J.A., Shariat S.F. et al. Renal-cell carcinoma risk estimates based on participants in the prostate, lung, colorectal, and ovarian cancer screening trial and national lung screening trial // Urol. Oncol. – 2016. – Vol. 34, №4. – P. e167-169. 16. Parra J., Drouin S. J., Hupertan V. et al. Oncological outcomes in patients under going radical nephrectomy and vena cava thrombectomy for renal cell carcinoma with venous extension: a single-centre experience // Europ. J. Surg. Oncol. – 2011. – Vol. 37, №5. – P. 422-428. 17. Rehn E. Gefass komplikation en und ihrebeherr schung beidem hypernephrom // Z. Urol. Chir. – 1922. – Vol. 10. – P. 326-332 18. Rigaud J., Hetet J.-F., Braudetal G. Surgical care, morbidity, mortality and follow-up after nephrectomy for renal cancer with extension of tumor thromb us in to thein ferior vena cava: retrospective study since 1990s // Europ. Urol. – 2006. – Vol. 50, №2. – P. 302-310 19. Shinder B.M., Rhee K., Farrell D. et al. Surgical Management of Advanced and Metastatic Renal Cell Carcinoma: A Multidisciplinary Approach // Front. Oncol. – 2017. – Vol. 31, №7. – Р. 107. 20. Skinner D.G., Pritchett T.R., Lieskovsky G. et al Vena caval involvement by renal cell carcinoma: surgical resection provides meaningful long-term survival// Ann. Surg. – 1989. – Vol. 210, №3. – P. 387-394. 21. Wagner B., Patard J.-J., Mґejean A. et al. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma // Europ. Urol. – 2009. – Vol. 55, №2. – P. 452-460. 22. Waters W.B., Richie J.P. Aggressive surgical approach to renal cell carcinoma review of 130 cases // J. Urol. – 1979. – Vol. 122. – P. 306-309. 23. Wong M.C.S., Goggins W.B., Yip B.H.K. et al. Incidence and mortality of kidney cancer: temporal patterns and global trends in 39 countries // Sci. Rep. – 2017. – Vol. 7, №1. – P. 15698. 24. Znaor A., Lortet-Tieulent J., Laversanne M. et al. International variations and trends in renal cell carcinoma incidence and mortality // Europ. Urol. – 2015. – Vol. 67, №3. – С. 519-530.

Share

COinS